PeopleDr John Beadle
Dr John Beadle
Dr John BeadleNon-executive DirectorJohn Beadle is a Non-Executive Director at Pneumagen. During his career, John has formed and led several innovative advanced therapy biotech companies through spin-outs, fundraising and acquisitions. Most recently, he co-founded InnDura therapeutics, a Boston, Massachusetts based NK cell therapy company where he is Chairman. Previously, John co-founded PowderMed, a DNA vaccine company, and PsiOxus (now Akamis), a clinical stage cancer gene therapy company. He served as CEO and Board Director of PsiOxus for over 12 years and as Chief Medical Officer and Board Director of PowderMed through to the successful acquisition by Pfizer.His background is medical, holding roles of increasing seniority in clinical development and medical operations at GSK. At GSK, John managed international teams, oversaw merger and post-integration operations, and led R&D and clinical development processes.John holds an MD from the University of Witwatersand, and an MBA from the London Business School.
active0
Roles
team_memberboard_chairexecutive
Timeline
Current Company
